Elythea
New Castle · Founded 2022
About Elythea
Elythea is an ML/DL-driven platform that obstetricians in any setting use to predict risk for complications of pregnancy (postpartum hemorrhage, c-section, eclampsia) before they ever happen. We use information that is available at the point of care, so we can make the prediction as early as the 1st trimester, allowing doctors months to prepare in advance! We use clinical history/demographic information that is available at the point-of-care, so we can make the prediction as early as the 1st trimester, in developed or developing countries, allowing doctors months to prepare in advance! Knowing high-risk earlier allows for blood/medicine/tailored clinical guidance to be prepared, reducing mortality/costs >90%. Our models use proprietary models to surpass gold standard risk assessments in the current clinical space. Our preliminary clinical trials have demonstrated 3x greater sensitivity for high risk classification of hemorrhage when comapred to the current widely used hemorrhage assessment score.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $593.0K
- Funding stage: Seed
- Last round: Non-Equity Assistance (Jul 2023)
- Website: https://elythea.org
Industries & Categories
Health Care, Hospital, Machine Learning, Software
Social Profiles
Canonical: https://fsome.com/organization/elythea-155910 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.